MGO One Seven’s Core Laboratories CLB Stock Holding History

MGO One Seven’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2	Closed	–	–	619
2018 Q4	$0	Buy	+2	New	+$173	﹤0.01%	1819
2018 Q1	$1K	Hold	5	–	–	﹤0.01%	1634
2017 Q4	$1K	Buy	+5	New	+$499	﹤0.01%	1617

Other funds holding CLB

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MGO One Seven's CLB Position: Q1 2019 in Review

MGO One Seven sold out of Core Laboratories (CLB) in Q1 2019, closing a stake of 2 shares.

MGO One Seven first reported a position in CLB in Q4 2017 and held it in 3 quarters. The position peaked at $1K in Q1 2018. 313 funds tracked by Wall St. Rank hold CLB as of Q1 2019.

MGO One Seven reported no remaining Core Laboratories position as of Q1 2019 after selling out during the quarter.
MGO One Seven sold 2 Core Laboratories shares in Q1 2019.
MGO One Seven first reported a position in Core Laboratories in Q4 2017 and held it in 3 quarters.
MGO One Seven's Core Laboratories position peaked at $1K in Q1 2018.
313 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2019.

Based on MGO One Seven's 13F filing for Q1 2019, filed 9 Apr 2019.